The global muscle relaxant drugs market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of people suffering from chronic pain and other conditions such as arthritis, fibromyalgia, and back pain. The increasing prevalence of these conditions has led to an increase in demand for muscle relaxants.
The global skeletal muscle relaxant drugs market is expected to grow at a CAGR of 4.6% during the forecast period, from 2021 to 2030. Skeletal muscle relaxants are used for treating spasms or cramps in muscles that are not caused by injury or disease but by stress or anxiety-related disorders such as tension headaches and irritable bowel syndrome (IBS). These drugs work by blocking nerve impulses that cause muscles contractions which leads to relaxation in muscles and relief from spasms or cramps.
The global facial muscle relaxant drugs market is expected to grow at a CAGR of 5% during the forecast period, from 2021 to 2030. Facial muscle relaxants are used for treating spasms or cramps in facial muscles due mainly due stress-related disorders such as tension headaches and irritable bowel syndrome (IBS). These drugs work by blocking nerve impulses that cause muscles contractions which leads them into relaxation in facial muscles leading relief from spasms or cramps.
- The global population is aging and the elderly are more susceptible to muscle spasms, which can be treated with muscle relaxant drugs.
- Muscle relaxant drugs are used to treat a variety of conditions such as chronic pain, fibromyalgia, and Parkinson's disease.
- The use of muscle relaxants for chronic pain has increased in recent years due to the opioid epidemic in North America and Europe.
- There is an increasing demand for non-addictive alternatives to opioids for treating chronic pain which can be met by muscle relaxant drugs such as baclofen or tizanidine that have been shown to reduce opioid consumption by up to 50%.
- Muscle relaxants are also used in surgery settings where they help patients recover from anesthesia faster and experience less post-operative discomfort.
Industry Growth Insights published a new data on “Muscle Relaxant Drugs Market”. The research report is titled “Muscle Relaxant Drugs Market research by Types (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs), By Applications (Hospital Pharmacies, Retail Pharmacies, Others), By Players/Companies Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Par Sterile Products, Acorda Therapeutics, SteriMax Inc, Emcure Pharmaceuticals, Upsher-Smith Laboratories, Orient Pharma, Daewoong Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Muscle Relaxant Drugs Market Research Report
By Type
Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs
By Application
Hospital Pharmacies, Retail Pharmacies, Others
By Companies
Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Par Sterile Products, Acorda Therapeutics, SteriMax Inc, Emcure Pharmaceuticals, Upsher-Smith Laboratories, Orient Pharma, Daewoong Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Muscle Relaxant Drugs Market Report Segments:
The global Muscle Relaxant Drugs market is segmented on the basis of:
Types
Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Allergan
- Ipsen Group
- Teva Pharmaceuticals
- Novartis
- Johnson & Johnson
- Takeda Pharmaceutical
- Sun Pharmaceutical
- Merz Pharma
- Mylan
- Fresenius Kabi
- Endo International
- Par Sterile Products
- Acorda Therapeutics
- SteriMax Inc
- Emcure Pharmaceuticals
- Upsher-Smith Laboratories
- Orient Pharma
- Daewoong Pharmaceutical
Highlights of The Muscle Relaxant Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Skeletal Muscle Relaxant Drugs
- Facial Muscle Relaxant Drugs
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Muscle Relaxant Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Muscle relaxants are medications that help to reduce muscle tension and pain. They are often used to treat conditions such as arthritis, back pain, and menstrual cramps.
Some of the major players in the muscle relaxant drugs market are Pfizer, Allergan, Ipsen Group, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Par Sterile Products, Acorda Therapeutics, SteriMax Inc, Emcure Pharmaceuticals, Upsher-Smith Laboratories, Orient Pharma, Daewoong Pharmaceutical.
The muscle relaxant drugs market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Muscle Relaxant Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Muscle Relaxant Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Muscle Relaxant Drugs Market - Supply Chain
4.5. Global Muscle Relaxant Drugs Market Forecast
4.5.1. Muscle Relaxant Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Muscle Relaxant Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Muscle Relaxant Drugs Market Absolute $ Opportunity
5. Global Muscle Relaxant Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Muscle Relaxant Drugs Market Size and Volume Forecast by Type
5.3.1. Skeletal Muscle Relaxant Drugs
5.3.2. Facial Muscle Relaxant Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Muscle Relaxant Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Muscle Relaxant Drugs Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Muscle Relaxant Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Muscle Relaxant Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Muscle Relaxant Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Muscle Relaxant Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Muscle Relaxant Drugs Demand Share Forecast, 2019-2026
9. North America Muscle Relaxant Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Muscle Relaxant Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Muscle Relaxant Drugs Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Muscle Relaxant Drugs Market Size and Volume Forecast by Type
9.7.1. Skeletal Muscle Relaxant Drugs
9.7.2. Facial Muscle Relaxant Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Muscle Relaxant Drugs Demand Share Forecast, 2019-2026
10. Latin America Muscle Relaxant Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Muscle Relaxant Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Muscle Relaxant Drugs Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Muscle Relaxant Drugs Market Size and Volume Forecast by Type
10.7.1. Skeletal Muscle Relaxant Drugs
10.7.2. Facial Muscle Relaxant Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Muscle Relaxant Drugs Demand Share Forecast, 2019-2026
11. Europe Muscle Relaxant Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Muscle Relaxant Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Muscle Relaxant Drugs Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Muscle Relaxant Drugs Market Size and Volume Forecast by Type
11.7.1. Skeletal Muscle Relaxant Drugs
11.7.2. Facial Muscle Relaxant Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.0. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Muscle Relaxant Drugs Demand Share, 2019-2026
12. Asia Pacific Muscle Relaxant Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Muscle Relaxant Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Muscle Relaxant Drugs Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Muscle Relaxant Drugs Market Size and Volume Forecast by Type
12.7.1. Skeletal Muscle Relaxant Drugs
12.7.2. Facial Muscle Relaxant Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Muscle Relaxant Drugs Demand Share, 2019-2026
13. Middle East & Africa Muscle Relaxant Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Muscle Relaxant Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Muscle Relaxant Drugs Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Muscle Relaxant Drugs Market Size and Volume Forecast by Type
13.7.1. Skeletal Muscle Relaxant Drugs
13.7.2. Facial Muscle Relaxant Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Muscle Relaxant Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Muscle Relaxant Drugs Market: Market Share Analysis
14.2. Muscle Relaxant Drugs Distributors and Customers
14.3. Muscle Relaxant Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Allergan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ipsen Group
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Takeda Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sun Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Merz Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Mylan
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Fresenius Kabi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Endo International
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Par Sterile Products
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Acorda Therapeutics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. SteriMax Inc
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Emcure Pharmaceuticals
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Upsher-Smith Laboratories
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Orient Pharma
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Daewoong Pharmaceutical
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
